Finally, treatment of T-ALL cell lines with NOTCH1 inhibitor γ-secretase (γ-SI) led to loss of H3K27ac from select (sensitive) enhancers, without affecting intra-TAD activity nor TAD boundary insulation. The gene discussed is NOTCH1; the disease is acute lymphoblastic leukemia.